Novartis India: Outpaces industry once again - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Novartis India: Outpaces industry once again

Jul 29, 2000

A 12% growth in the topline has led to a commensurate growth in the bottomline for Novartis India. While the operating margins have improved, higher depreciation has nullified the rise in operating margins.

(Rs m) 1QFY00 1QFY01 Change
Sales 1,879 2,106 12.1%
Other Income 53 66 24.5%
Expenditure 1,633 1,824 11.7%
Operating Profit (EBDIT) 246 282 14.6%
Operating Profit Margin (%) 13.1% 13.4%  
Interest 5 4 -20.0%
Depreciation 28 44 57.1%
Profit before Tax 266 300 12.8%
Other Adjustments      
Tax 100 114 14.0%
Profit after Tax/(Loss) 166 186 12.0%
Net profit margin (%) 8.8% 8.8%  
No. of Shares (m) (eoy) 31.9 31.9  
Diluted no. of shares (m) 31.9 31.9  
Diluted Earnings per share* 20.8 23.3  
*(annualised)      

The company has already announced the demerger of the agrichemical business and a 2:1 split (which implies a face value of Rs 5). This would become effective with retrospective effect from April 1, 2000. The current quarter's results however include the operations of the agrichemical division.

Once the split becomes effective the company's operating margins are expected to improve to levels of 16% plus. The inventory and the debtors can also be expected to reduce to levels of around 45 days from the present levels of around 70 days.

The stock quotes at a level of Rs 887 which implies an earning multiple of 38 times FY2001 earnings. The stock has shot up almost 43% in the last two months since the spin off of the agribusiness and 2:1 split was announced.


Equitymaster requests your view! Post a comment on "Novartis India: Outpaces industry once again". Click here!

  

More Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

I Believe These Stocks Will Deliver the Most Outsized Returns in 2021 and Beyond (Profit Hunter)

Sep 23, 2020

Rules of the racetrack can help you bag the biggest gainers of the coming decade.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Oct 1, 2020 12:49 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS